Correlation Between Achilles Therapeutics and Rezolute

Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Achilles Therapeutics PLC and Rezolute, you can compare the effects of market volatilities on Achilles Therapeutics and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Rezolute.

Diversification Opportunities for Achilles Therapeutics and Rezolute

0.09

Correlation Coefficient

Achilles Therapeutics  Rezolute

Significant diversification

The 3 months correlation between Achilles and Rezolute is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Rezolute go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Rezolute

Given the investment horizon of 90 days Achilles Therapeutics is expected to generate 2.81 times less return on investment than Rezolute. But when comparing it to its historical volatility, Achilles Therapeutics PLC is 1.44 times less risky than Rezolute. It trades about 0.03 of its potential returns per unit of risk. Rezolute is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  198.00  in Rezolute on September 16, 2024 and sell it today you would earn a total of  261.00  from holding Rezolute or generate 131.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Achilles Therapeutics PLC  vs.  Rezolute

Achilles Therapeutics PLC

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Rezolute

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Achilles Therapeutics and Rezolute

The main advantage of trading using opposite Achilles Therapeutics and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.

The idea behind Achilles Therapeutics PLC and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.